Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,000 shares at $201.32 ($607K) on 2026-04-01, disclosed to the SEC on 2026-04-03.
Scheduled sale ($607k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $201.32 | 1,048 | $211K | 34.8% |
| 2 | $202.36 | 1,000 | $202K | 33.3% |
| 3 | $203.31 | 952 | $194K | 31.9% |
| Total | $202.30 avg | 3,000 | $607K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |